| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | BIOGEN |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$1,460,000 | |
| 2025 | BIOGEN |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$770,000 | |
| 2025 | BIOGEN |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$990,000 | |
| 2025 | BIOGEN |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$1,380,000 | |
| 2025 | BIOGEN |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$1,020,000 | |
| 2024 | BIOGEN |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$700,000 | |
| 2024 | BIOGEN |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$710,000 | |
| 2024 | BIOGEN |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$1,670,000 | |
| 2024 | BIOGEN |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$1,060,000 | |
| 2023 | BIOGEN |
2nd Quarter (Apr 1 - June 30) AMENDED |
$830,000 |
| Firm | Filings | Expenses |
|---|---|---|
| BIOGEN | 79 | $49,391,680 |
| Issue | Activities |
|---|---|
| Health Issues | 79 |
| Medicare/Medicaid | 78 |
| Taxation/Internal Revenue Code | 64 |
| Copyright/Patent/Trademark | 60 |
| Trade (domestic/foreign) | 53 |
| Pharmacy | 27 |
| Budget/Appropriations | 7 |
| Manufacturing | 3 |
| Transportation | 1 |